Genelux (GNLX) said Monday that Matthew Pulisic has assumed the role of chief financial officer of the company starting Jan. 30.
Pulisic most recently served as vice president of finance at Arrowhead Pharmaceuticals (ARWR).
Shares of Genelux were down nearly 10% in recent trading.
Price: 3.56, Change: -0.39, Percent Change: -9.87
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.